ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $902,000 | -10.2% | 43,366 | -10.3% | 0.01% | -14.3% |
| Q4 2016 | $1,005,000 | -52.1% | 48,334 | -24.5% | 0.01% | -58.8% |
| Q3 2016 | $2,097,000 | +10.5% | 63,978 | +11.4% | 0.02% | -10.5% |
| Q4 2015 | $1,898,000 | -91.5% | 57,452 | -15.6% | 0.02% | -20.8% |
| Q3 2015 | $22,312,000 | +1019.5% | 68,106 | +81.0% | 0.02% | +41.2% |
| Q2 2015 | $1,993,000 | +278.2% | 37,629 | +106.1% | 0.02% | +325.0% |
| Q1 2015 | $527,000 | – | 18,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |